Dialysis News and Research

Latest Dialysis News and Research

Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients

The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events.

2 Sep 2009

Study reveals that baking soda benefits patients with advanced chronic kidney disease

A daily dose of sodium bicarbonate—baking soda, already used for baking, cleaning, acid indigestion, sunburn, and more—slows the decline of kidney function in some patients with advanced chronic kidney disease (CKD), reports an upcoming study in the Journal of the American Society of Nephrology (JASN).

2 Sep 2009

Heart health of kidney disease patients not affected by dialysis treatment

Dialysis treatments do not affect the heart health of kidney disease patients who have had a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Since cardiovascular disease is the most common cause of death in kidney disease patients, the findings are good news for individuals who need the treatments.

1 Sep 2009

Davita Chairman is one of 100 Most Powerful People in Healthcare

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced that Modern Healthcare Magazine, one of the nation's leading health care industry publications, named Kent Thiry, Chairman and CEO for DaVita(R), as one of the 100 Most Powerful People in Healthcare in 2009.

1 Sep 2009

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its nocturnal dialysis patient population has reached a milestone, with 1,000 patients having received this life-saving treatment in more than 90 DaVita(R) centers around the nation. DaVita has one of the largest nocturnal patient populations in the country.

28 Aug 2009

AgaMatrix educates health care professionals and patients on the importance of blood glucose meter accuracy

AgaMatrix, Inc., the makers of WaveSense blood glucose meters, announced today their continued commitment to educate health care professionals and patients on the importance of blood glucose meter (BGM) accuracy for all patients.

28 Aug 2009

Blood thinner warfarin may have opposite effects in kidney disease patients on dialysis

The blood thinner warfarin can prevent strokes in most individuals with abnormal heart rhythms, but the drug may have the opposite effect in kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that warfarin should be prescribed with caution in patients with kidney failure.

27 Aug 2009

DaVita to present three abstracts on Peritoneal Dialysis at the ISPD meeting

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research(R), today announced that it will present three abstracts at the 3rd North American Chapter meeting of the International Society for Peritoneal Dialysis (ISPD) on August 27-29 in Vancouver, British Columbia.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Diplomat Specialty Pharmacy and Ohio Caresource collaborate to develop Chronic Kidney Disease treatment

Diplomat Specialty Pharmacy announced today that its Diplomat Health Services Division is partnering with CareSource in Ohio to slow the progression of Chronic Kidney Disease (CKD), improve clinical outcomes and reduce healthcare costs associated with the disease. As the number of Americans with CKD continues to rise, CareSource is focused on the early identification and treatment of their patients with the illness.

25 Aug 2009

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ: APCVZ), announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market penicillin G potassium for Injection, USP, in two dosage strengths. Penicillin G is therapeutically equivalent to the reference drug PfizerPen™ G, which is marketed by the innovator Pfizer, Inc.

25 Aug 2009

National dialysis treatment program under fire; criticized as too costly, risky

Kidney dialysis treatment in the U.S. is costly and has high death rates, but it doesn't have to be that way, USA Today reports: "The vast majority of the more than 350,000 Americans on dialysis are treated in centers, where three treatments a week, three or four hours each, is the norm — not because it's optimal but because that's the way it has been done for nearly four decades.

25 Aug 2009

Fresenius Medical Care's Patient Travel Service to provide free dialysis scheduling assistance to travelling patients

As thousands of people plan getaways for the fall and winter travel seasons, easy access to healthcare is a concern for many travelers with chronic health conditions who require life-sustaining treatments. Twenty-six million Americans suffer from chronic kidney disease, and more than 355,000 of them require dialysis every few days to stay alive.

24 Aug 2009

Night home hemodialysis offers similar benefits as kidney transplants

For the first time, it has been shown that patients who receive night home hemodialysis live just as long as those who receive kidney transplants from deceased donors.

21 Aug 2009

Illegal immigrant dialysis in Las Vegas costly to hospitals, system

The Las Vegas Review-Journal reports that dialysis care for illegal immigrants at a taxpayer-supported medical center costs $20 million a year and that the immigrants are being referred there from for-profit hospitals.

21 Aug 2009

New portable dialysis machine that provides continuous dialysis is under development

Researchers are developing a Wearable Artificial Kidney for dialysis patients, reports an upcoming paper in the Clinical Journal of the American Society of Nephrology (CJASN). "Our vision of a technological breakthrough has materialized in the form of a Wearable Artificial Kidney, which provides continuous dialysis 24 hours a day, seven days a week," comments Victor Gura, MD (David Geffen School of Medicine at UCLA).

21 Aug 2009

Proposed Federal budget cuts will put seniors at risk

The Health Facilities Association of Maryland (HFAM) today brought together U.S. Representative Frank Kratovil (MD-1) and residents, workers and leaders from the Salisbury Rehabilitation and Nursing Center to personalize the pending effects of a proposed $32 billion federal cut to Medicare.

20 Aug 2009

Study reveals that patient care is better in nonprofit nursing homes than in for-profit nursing homes

A major new statistical review of 82 individual research studies has revealed that nonprofit nursing homes deliver, on average, higher quality care than for-profit nursing homes. The findings could have a bearing on the present debate about the role of for-profit firms in U.S. health reform.

20 Aug 2009

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Gentium S.p.A. has announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to evaluate the safety and efficacy of 25 mg/kg/day of Defibrotide for the treatment of severe veno-occlusive disease (sVOD) in hematopoietic stem cell transplant (SCT) patients.

19 Aug 2009

Genetic mutation that helps regulate high blood pressure is a cause of inherited kidney disease

The discovery provides insight into a protein, renin, that is important in blood pressure regulation, and reveals the cause of one type of inherited kidney disease occurring in adults and children, said co-investigator Anthony Bleyer, M.D., professor of internal medicine-nephrology at the School of Medicine.

19 Aug 2009

Dialysis News and Research

Latest Dialysis News and Research

Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients

Study reveals that baking soda benefits patients with advanced chronic kidney disease

Heart health of kidney disease patients not affected by dialysis treatment

Davita Chairman is one of 100 Most Powerful People in Healthcare

DaVita's nocturnal dialysis treatment allows patients to dialyze in-clinic while sleeping overnight

AgaMatrix educates health care professionals and patients on the importance of blood glucose meter accuracy

Blood thinner warfarin may have opposite effects in kidney disease patients on dialysis

DaVita to present three abstracts on Peritoneal Dialysis at the ISPD meeting

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Diplomat Specialty Pharmacy and Ohio Caresource collaborate to develop Chronic Kidney Disease treatment

FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP

National dialysis treatment program under fire; criticized as too costly, risky

Fresenius Medical Care's Patient Travel Service to provide free dialysis scheduling assistance to travelling patients

Night home hemodialysis offers similar benefits as kidney transplants

Illegal immigrant dialysis in Las Vegas costly to hospitals, system

New portable dialysis machine that provides continuous dialysis is under development

Proposed Federal budget cuts will put seniors at risk

Study reveals that patient care is better in nonprofit nursing homes than in for-profit nursing homes

Gentium reports results from phase 3 trial of defibrotide for severe veno-occlusive disease

Genetic mutation that helps regulate high blood pressure is a cause of inherited kidney disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in